From Bio Co.,Ltd Statistics

Total Valuation

From Bio Co.,Ltd has a market cap or net worth of KRW 52.40 billion. The enterprise value is 71.28 billion.

Market Cap	52.40B
Enterprise Value	71.28B

Important Dates

The next estimated earnings date is Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	n/a

Share Statistics

From Bio Co.,Ltd has 28.31 million shares outstanding. The number of shares has increased by 0.12% in one year.

Current Share Class	n/a
Shares Outstanding	28.31M
Shares Change (YoY)	+0.12%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	40.27%
Owned by Institutions (%)	9.03%
Float	16.78M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.78
PB Ratio	0.85
P/TBV Ratio	0.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.12
EV / Sales	1.07
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.89

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of 0.44.

Current Ratio	1.41
Quick Ratio	0.37
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-1.09
Interest Coverage	-26.67

Financial Efficiency

Return on equity (ROE) is -25.40% and return on invested capital (ROIC) is -16.20%.

Return on Equity (ROE)	-25.40%
Return on Assets (ROA)	-14.98%
Return on Capital (ROIC)	-16.20%
Revenue Per Employee	522.13M
Profits Per Employee	-135.23M
Employee Count	128
Asset Turnover	0.71
Inventory Turnover	0.96

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -67.70% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-67.70%
50-Day Moving Average	2,026.22
200-Day Moving Average	2,146.37
Relative Strength Index (RSI)	33.30
Average Volume (20 Days)	41,962

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, From Bio Co.,Ltd had revenue of KRW 66.83 billion and -17.31 billion in losses. Loss per share was -611.05.

Revenue	66.83B
Gross Profit	43.50B
Operating Income	-22.53B
Pretax Income	-23.02B
Net Income	-17.31B
EBITDA	-20.32B
EBIT	-22.53B
Loss Per Share	-611.05

Full Income Statement

Balance Sheet

The company has 7.11 billion in cash and 26.82 billion in debt, giving a net cash position of -19.71 billion or -696.13 per share.

Cash & Cash Equivalents	7.11B
Total Debt	26.82B
Net Cash	-19.71B
Net Cash Per Share	-696.13
Equity (Book Value)	61.11B
Book Value Per Share	2,188.17
Working Capital	10.67B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -23.13 billion and capital expenditures -1.54 billion, giving a free cash flow of -24.68 billion.

Operating Cash Flow	-23.13B
Capital Expenditures	-1.54B
Free Cash Flow	-24.68B
FCF Per Share	-871.61

Full Cash Flow Statement

Margins

Gross margin is 65.08%, with operating and profit margins of -33.71% and -25.90%.

Gross Margin	65.08%
Operating Margin	-33.71%
Pretax Margin	-34.45%
Profit Margin	-25.90%
EBITDA Margin	-30.40%
EBIT Margin	-33.71%
FCF Margin	n/a

Dividends & Yields

From Bio Co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.12%
Shareholder Yield	-0.12%
Earnings Yield	-33.01%
FCF Yield	-47.09%

Stock Splits

The last stock split was on March 13, 2024. It was a forward split with a ratio of 2.

Last Split Date	Mar 13, 2024
Split Type	Forward
Split Ratio	2

Scores

From Bio Co.,Ltd has an Altman Z-Score of 1.59. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.59
Piotroski F-Score	n/a